| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004258888 |
| P356 | DOI | 10.1186/GM395 |
| P932 | PMC publication ID | 4064315 |
| P698 | PubMed publication ID | 23199229 |
| P5875 | ResearchGate publication ID | 233825579 |
| P50 | author | Thomas Hankemeier | Q28540616 |
| P2093 | author name string | Age K Smilde | |
| Ruud Berger | |||
| Ewa Szymańska | |||
| Sandrine Ellero-Simatos | |||
| Ton Rullmann | |||
| Raymond Ramaker | |||
| Thijs Mp van Iersel | |||
| Wim Ha Dokter | |||
| Wynand Alkema | |||
| P2860 | cites work | Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes | Q46480493 |
| Quantitative importance of non-skeletal-muscle Nτ-methylhistidine and creatine in human urine | Q46599852 | ||
| Potential use of 3-methylhistidine excretion as an index of progressive reduction in muscle protein catabolism during starvation | Q47949989 | ||
| Glucocorticosteroids increase leucine oxidation and impair leucine balance in humans. | Q51618629 | ||
| Different patterns of protein turnover in skeletal and gastrointestinal smooth muscle and the production of N tau-methylhistidine during fasting in the rat. | Q51634903 | ||
| A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human | Q57016081 | ||
| Dehydroepiandrosterone Replacement Therapy | Q61237958 | ||
| Impact of Acute and Chronic Low-Dose Glucocorticoids on Protein Metabolism | Q61847128 | ||
| Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative | Q70385603 | ||
| Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation | Q71263658 | ||
| RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism | Q72625216 | ||
| Anti-inflammatory actions of glucocorticoids: molecular mechanisms | Q77686959 | ||
| Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance | Q83938388 | ||
| Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects | Q24630458 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport | Q34606304 | ||
| Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile | Q34717142 | ||
| Mechanisms involved in the side effects of glucocorticoids | Q35003894 | ||
| Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. | Q35091608 | ||
| Regulation of renal amino acid (AA) transport by hormones, drugs and xenobiotics - a review | Q35136705 | ||
| A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake | Q36301541 | ||
| Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men | Q37120388 | ||
| Mechanisms of glucocorticoid-induced myopathy | Q37121299 | ||
| Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome | Q37146918 | ||
| Applications of metabolomics in drug discovery and development | Q37249682 | ||
| Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism | Q37318311 | ||
| Human urinary metabolomic profile of PPARalpha induced fatty acid beta-oxidation. | Q37383330 | ||
| Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? | Q37387727 | ||
| Nicotinamide overload may play a role in the development of type 2 diabetes | Q37461169 | ||
| Short-term prednisone use antagonizes insulin's anabolic effect on muscle protein and glucose metabolism in young healthy people | Q37474436 | ||
| Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity | Q37637235 | ||
| Glucocorticoid-induced myopathy | Q37753145 | ||
| The renal handling of amino acids and oligopeptides | Q39652707 | ||
| Analysis of the adult human plasma metabolome | Q40107287 | ||
| Human growth hormone prevents the protein catabolic side effects of prednisone in humans | Q40347651 | ||
| Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women | Q41362013 | ||
| Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of Nτ-methylhistidine | Q41543292 | ||
| Quantitative importance of non-skeletal-muscle sources of N tau-methylhistidine in urine | Q41935552 | ||
| Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis | Q41952903 | ||
| Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance | Q42496873 | ||
| Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes | Q42816694 | ||
| Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men. | Q43177498 | ||
| Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle | Q44004415 | ||
| Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans | Q44104217 | ||
| Adrenopause: an imbalance between dehydroepiandrosterone (DHEA) and cortisol secretion. | Q44267380 | ||
| Regulation of L-leucine transport in rat kidney by dexamethasone and triiodothyronine | Q44498114 | ||
| Influence of age and resistance exercise on human skeletal muscle proteolysis: a microdialysis approach | Q44649196 | ||
| Neuroendocrine hypothesis of aging: the role of corticoadrenal steroids. | Q45104727 | ||
| Discovery of metabolomics biomarkers for early detection of nephrotoxicity | Q46043673 | ||
| P433 | issue | 11 | |
| P921 | main subject | metabolic profiling | Q116909045 |
| P304 | page(s) | 94 | |
| P577 | publication date | 2012-11-30 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | Assessing the metabolic effects of prednisolone in healthy volunteers using urine metabolic profiling | |
| P478 | volume | 4 |
| Q41125941 | Acute interaction between hydrocortisone and insulin alters the plasma metabolome in humans |
| Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
| Q44559241 | Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats |
| Q61449270 | Immunohistochemical Labeling of Low-Density Lipoprotein Receptor and Scavenger Receptor Class B Type 1 Are Increased in Canine Lymphoma |
| Q41376761 | Impact of different immunosuppressive regimens on the health-related quality of life following orthotopic liver transplantation |
| Q47134637 | Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia. |
Search more.